Elsevier And MediMedia MAP Partner In Health

AMSTERDAM, August 1 /PRNewswire/ -- Elsevier, a leading global healthcare and scientific publisher, announced today that it has bought MediMedia's professional medical publishing businesses ("MediMedia MAP"). This expands existing publishing programs and digital services, accelerates growth, and meets the demand for structured continuing education amongst medical and allied healthcare professionals worldwide.

MediMedia MAP is a key provider of medical information in rapidly growing international healthcare markets. Based in France, Spain, the US, the UK, Italy and Mexico, MediMedia MAP publishes the prestigious imprints of Masson, Doyma and Netter, providing medical books, journals and reference information for the practitioner market as well as continuing medical education and pharmaceutical industry-sponsored communications.

"Needless to say, we are delighted that MediMedia MAP's key geographic markets, established titles, and specific areas of expertise provide such an excellent complement to Elsevier's," commented Brian Nairn, CEO of Elsevier's Health Sciences, "We are confident that our global health publishing activities will provide our customers with enriched solutions and resources, further contributing to their professional success."

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in 71 offices worldwide publish more than 2,000 journals and 2,200 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


CONTACT: Marike Westra, Tel: +31-20-485-2736, E-mail:marike.westra@elsevier.com

Back to news